American journal of cardiovascular disease最新文献

{"title":"The implementation of a value-based learning health system for preventative care in Ontario, Canada.","authors":"Aaron Rosenfeld,&nbsp;Jillian Ball,&nbsp;Sara Rattanasithy,&nbsp;Christine Tsilas,&nbsp;Rachel Miller,&nbsp;Joanne Berardi,&nbsp;Alaina Pupulin,&nbsp;Carolina Carvalho,&nbsp;Samantha Segal,&nbsp;Shaul Kruger,&nbsp;Ravi Bajaj,&nbsp;David Alter","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>While value-based learning health systems may address challenges associated with the integrative delivery of therapeutic lifestyle management in usual care, the extent to which they have been evaluated in real-world settings have remained limited.</p><p><strong>Methods: </strong>To explore the feasibility and user-experiences, associated with the first-year implementation of a preventative Learning Health System (LHS), consecutive patients were evaluated following referral from primary and/or specialty care providers from the Halton and Greater Toronto Area in Ontario, Canada, between December 2020 and December 2021. The integration of a LHS into medical care was facilitated using a digital e-learning platform, and consisted of exercise, lifestyle, and disease-management counselling. The dynamic monitoring of user-data allowed patients and providers to modify goals, treatment plans, and care-delivery in real-time in accordance with patient engagement, weekly exercise, and risk-factor targets. All program costs were covered by the public-payer health care system using a physician fee-for-service payment model. Descriptive statistics evaluated attendance to prescheduled visits, drop-out rates, changes in self-reported weekly Metabolic Expenditure Task-Minutes (MET-MINUTES), perceived changes in health knowledge, lifestyle behaviours, health status, satisfaction with care, and programmatic costs.</p><p><strong>Results: </strong>378 of 437 patients (86.5%) enrolled in the 6-month program; The average age of patients was 61.2 ± 12.2, 156 (41.3%) of which were female and 140 (37.0%) with established coronary disease. After 1 year, 15.6% dropped out of the program. On average, weekly MET-MINUTES rose by 191.1 throughout the program (95% CI [331.82, 57.96], P=0.007), with increases most prominent among sedentary populations. Participants reported significant improvements in perceived health status and health knowledge, at a total health-care delivery cost of $517.70 per patient for a completed program.</p><p><strong>Conclusion: </strong>The implementation of an integrative preventative learning health system was feasible, with high patient engagement and favourable user-experiences. Further research is required to compare health outcomes against usual care.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 2","pages":"87-100"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193245/pdf/ajcd0013-0087.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9507548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In-hospital outcomes of acute ischaemic stroke patients with atrial septal defect. A national inpatient sample study.","authors":"Tiberiu Alexandru Pana,&nbsp;Fiona Craigen,&nbsp;Mohamed O Mohamed,&nbsp;Mamas A Mamas,&nbsp;Phyo Kyaw Myint","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background and aims: </strong>Atrial septal defects (ASD) are a well-recognised risk factor for acute ischaemic stroke (AIS). We aimed to delineate the relationship between ASD and in-hospital AIS outcomes (mortality, severe stroke (National Institutes of Health Stroke Scale (NIHSS) > 15), prolonged hospitalisation > 4 days and routine home discharge) in contemporary practice using data from the United States National Inpatient Sample.</p><p><strong>Methods: </strong>NIS admissions with a primary diagnosis of AIS between 2016-2018 were extracted. The NIHSS variable had 75% missing data, which were imputed using multiple imputations by chained equations. The relationship between ASD and the main outcomes was modelled using multivariable logistic regressions, adjusting for age, sex, comorbidities, stroke severity and revascularisation therapies.</p><p><strong>Results: </strong>245,859 records representative of 1,229,295 AIS admissions were included, 35,840 (2.91%) of whom had ASD. ASD patients were younger (median age 63 years versus 72 years) and less likely to have traditional cardiovascular risk factors than their counterparts without ASD. ASD was independently associated with 58% lower odds of in-hospital mortality (hazard ratio (95% confidence interval) = 0.42 (0.33-0.54)), 18% lower odds of severe stroke (0.82 (0.71-0.94)), 20% higher odds of routine home discharge (1.20 (1.14-1.28)) and 28% higher odds of prolonged hospitalisation (1.28 (1.21-1.35)).</p><p><strong>Conclusions: </strong>ASD was associated with better in-hospital outcomes, which were likely driven by younger age, lower prevalence of traditional cardiovascular risk factors, and lower stroke severity. Further research is warranted to clarify the ASD anatomical characteristics which are most strongly associated with these associations.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 3","pages":"183-191"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352813/pdf/ajcd0013-0183.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10202727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Right heart catheterization in clinical practice: a review of basic physiology and important issues relevant to interpretation.","authors":"Gaspar Del Rio-Pertuz,&nbsp;Kenneth Nugent,&nbsp;Erwin Argueta-Sosa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pulmonary artery catheterization is a diagnostic procedure in which a catheter is inserted through a central vein and advanced toward the pulmonary artery to measure right atrial, right ventricular, and pulmonary artery pressures, estimate cardiac output, identify intracardiac shunts, and measure pulmonary vascular resistance. Hemodynamic measurements can provide a better understanding of the pathophysiology of heart failure and pulmonary hypertension, but their proper assessment and optimal use can be challenging due to differences in techniques that can lead to differences in conclusions and therapeutic management strategies. In this review, we will discuss right heart catheterization and its role in clinical practice (e.g., shunt evaluation, management of cardiogenic shock) and summarize important concerns related to measurement and interpretation.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 3","pages":"122-137"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352814/pdf/ajcd0013-0122.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10202731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In vitro modeling of crimped Dacron vascular grafts for aortic root replacement.","authors":"Rakan I Nazer,&nbsp;Abdulaziz Alhothali,&nbsp;Ali Albarrati","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To objectively quantify the effect of flattening the crimps in Dacron tube grafts on the radial compliance under pulsatile pressure. We aimed to minimize the dimensional changes in woven Dacron graft tubes by applying axial stretch to the graft. We hypothesize this might reduce the risk of coronary button misalignment in aortic root replacement.</p><p><strong>Methods: </strong>In an in vitro pulsatile model that delivered systemic circulatory pressures to Dacron tube grafts, we measured oscillatory movements in 26-30 mm Dacron vascular tube grafts before and after flattening the graft crimps. We also describe our surgical methods and clinical experiences in replacing the aortic root.</p><p><strong>Results: </strong>Flattening the crimps in Dacron tubes with axial stretching significantly reduced the mean maximal oscillation distance measured radially during each balloon pulse (3.2 ± 0.8 mm, 95% CI: 2.6, 3.7 mm vs. 1.5 ± 0.5 mm, 95% CI: 1.2, 1.7 mm; P < 0.001).</p><p><strong>Conclusion: </strong>The radial compliance of woven Dacron tubes was significantly reduced after flattening the crimps. Applying axial stretch to the Dacron grafts prior to determining the coronary button attachment site can help maintain dimensional stability in the graft, which may reduce the risk of coronary malperfusion in aortic root replacment.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 2","pages":"59-67"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193250/pdf/ajcd0013-0059.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9502283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Myocarditis in COVID-19: a focus on the pediatric population.","authors":"Bshara Sleem,&nbsp;Rana Zareef,&nbsp;Fadi Bitar,&nbsp;Mariam Arabi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The emergence of the novel SARS-CoV-2 virus in late 2019 introduced new, unpreceded global challenges. Complications arising from COVID-19 widely range from mild to severe and, in some cases, lead to death. The myocardium has proven to be a potential target site for this virus, and has been affected at various levels, resulting in numerous complications, including myocarditis. This article represents a thorough and updated literature review on the clinical manifestations of COVID-19 that pertain to myocarditis, its molecular basis, diagnostic modalities, and treatment approaches, with a special focus on the pediatric population. There definitely is a link between COVID-19 and myocarditis, but the manifestations of this relationship vary from one case to another. At the molecular level, various viral and immunologic factors contribute to the development of myocarditis. Diagnosis, treatment, and outcomes vary as well, but some common trends can be noted. Proper and prompt diagnosis and treatment of SARS-CoV-2-induced myocarditis are crucial. Unfortunately, data in the literature suffers from conspicuous scarcity, especially for the pediatric population; thus, further large-scale clinical studies are required to attain clear and effective guidelines.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 3","pages":"138-151"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352818/pdf/ajcd0013-0138.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9844513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of dyslipidaemia in OSA patients at a tertiary care center.","authors":"Jyoti Bajpai,&nbsp;Akshyaya Pradhan,&nbsp;Darshan Bajaj,&nbsp;Ajay Kumar Verma,&nbsp;Surya Kant,&nbsp;Akhilesh Kumar Pandey,&nbsp;Rishi Sethi,&nbsp;Abhishek Dubey","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Background Obstructive sleep apnea (OSA) is associated with many diseases, but evidence indicating that OSA is a risk factor for dyslipidemia is lacking. Aim This cross-sectional study investigated the prevalence of lipid abnormalities in patients with OSA and its association with OSA severity.</p><p><strong>Material and methods: </strong>In this cross-sectional study, 102 patients with suspected OSA underwent standard polysomnography. All patients with an apnea-hypopnea index (AHI) of ≥5 with symptoms were diagnosed as having OSA. A fasting blood sample was collected from all patients. Blood levels of triglycerides (TGs), total cholesterol (TC), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL) were measured. The relationship between the AHI and lipid profiles was analyzed, and linear regression analysis was performed to evaluate the effect of dyslipidemia on OSA.</p><p><strong>Results: </strong>The patients with OSA had a significantly higher TG level and a significantly lower HDL level than did those without OSA. The lipid abnormalities increased with OSA severity. The mean serum TG level was higher in the severe OSA group (175±46.5 vs. 153±42.45, mg/dl P = 0.048), and the mean serum HDL level was lower in the severe OSA group (38.43 ± 5.19 vs. 45.73 ± 4.98, mg/dl P = 0.004). Serum TG, cholesterol, and LDL levels were correlated with a BMI of <30 and a BMI of >30 in the OSA group. Linear regression analysis indicated that only age (β = 0.301, P = 0.000), BMI (β = 0.455, P = 0.000), serum HDL level (β = -0.297, P = 0.012), and serum LDL level (β = 0.429, P = 0.001) were the independent predictors of OSA.</p><p><strong>Conclusion: </strong>OSA and obesity are potential risk factors for dyslipidemia. The diagnosis of hyperlipidemia was linked to OSA, and the association was more significant with OSA severity. Hyperlipidemia was well recognized in patients with OSA. LDL and HDL are the independent predictors of OSA.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 1","pages":"1-9"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017921/pdf/ajcd0013-0001.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9141104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Accura balloon dilatation catheter for percutaneous balloon pulmonary valvuloplasty among adult patients-its protean use.","authors":"Najeeb Ullah Sofi,&nbsp;Mohit Sachan,&nbsp;Santosh K Sinha,&nbsp;Mukesh J Jha,&nbsp;Umeshwar Pandey,&nbsp;Mahmodullah Razi,&nbsp;Awadhesh K Sharma,&nbsp;Praveen Shukla,&nbsp;Puneet Aggarwal,&nbsp;Kumar Himanshu,&nbsp;Prachi Sharma,&nbsp;Ramesh Thakur","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Percutaneous balloon pulmonary valvuloplasty (PBPV) is the treatment of choice for hemodynamically significant pulmonary stenosis (PS). Currently, the Tyshak balloon is preferred but requires multiple dilatations because of its instability across the valve leading to a watermelon seeding effect. Accura balloon (Vascular Concept, UK) offers an advantage in its self-positioning configuration, variable diameter, and rapid inflation-deflation sequence which shortens the procedural time and valve injury.</p><p><strong>Method: </strong>43 patients with severe pulmonary valve stenosis underwent PBPV using an Accura balloon at LPS Institute of Cardiology, GSVM Medical College, Kanpur, UP, India from March 2018 to February 2022. The procedure was carried out using the standard technique but the metallic straightener was removed when the catheter reached the right atrium to facilitate its delivery across the pulmonary valve. Patients were followed up by 2D echo at 24 hours and 6 months.</p><p><strong>Result: </strong>Successful BPV was done in all 43 patients [with mean age 21.9 (range 18-41); 31 males and 12 females] among which 5 patients had dysplastic valves. The mean diameter of the annulus was 18.5 (range 15-21) mm. Immediate hemodynamic improvement was observed in 38 patients (88%) as peak systolic gradient reduced from 84±13 to 22±12 mmHg (P<0.005) while 5 patients (12%) had <50% reduction of resting gradient, though it came down significantly at 6 months. Fluoroscopy and procedural time were 5.2±1.9 min and 22.6±3.4 min respectively. Major complications (death, cardiac perforation, tamponade, tricuspid regurgitation, requirement of blood transfusion) were none. Minor complications (transient hypotension, ventricular premature contraction, transient bradycardia) were reported in all patients. Accura balloon being bulky were delivered over left atrial and super stiff Amplatz wire in 36 and 7 patients respectively.</p><p><strong>Conclusion: </strong>PBPV using Accura balloon is safe and effective for both stenosed and dysplastic valves. In a few patients, maximal effect will be observed over a period of 6 months.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 3","pages":"152-161"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352819/pdf/ajcd0013-0152.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9844521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An exploration of the early discharge approach for low-risk STEMI patients following primary percutaneous coronary intervention.","authors":"Nicole Broughton,&nbsp;Katrina Comer,&nbsp;Oliver Casey-Gillman,&nbsp;Lizze Moore,&nbsp;Sotiris Antoniou,&nbsp;Riyaz Patel,&nbsp;Sadeer Fhadil,&nbsp;Paul Wright,&nbsp;Muhiddin Ozkor,&nbsp;Oliver Guttmann,&nbsp;Andreas Baumbach,&nbsp;Andrew Wragg,&nbsp;Ajay J Jain,&nbsp;Fizzah Choudry,&nbsp;Anthony Mathur,&nbsp;Krishnaraj S Rathod,&nbsp;Daniel A Jones","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Recently, there has been growing interest in the early discharge strategy for low-risk patients who have undergone primary percutaneous coronary intervention (PCI) to treat ST-segment elevation myocardial infarction (STEMI). So far findings have suggested there are multiple advantages of shorter hospital stays, including that it could be a safe way to be more cost- and resource-efficient, reduce cases of hospital-acquired infection and boost patient satisfaction. However, there are remaining concerns surrounding safety, patient education, adequate follow-up and the generalisability of the findings from current studies which are mostly small-scale. By assessing the current research, we describe the advantages, disadvantages and challenges of early hospital discharge for STEMI and discuss the factors that determine if a patient can be considered low risk. If it is feasible to safely employ a strategy like this, the implications for healthcare systems worldwide could be extremely beneficial, particularly in lower-income economies and when we consider the detrimental impacts of the recent COVID-19 pandemic on healthcare systems.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 2","pages":"32-42"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193248/pdf/ajcd0013-0032.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10301119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV.","authors":"Robert J Henning,&nbsp;John N Greene","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>More than 1.2 million people in the United States have Human Immunodeficiency Virus (HIV) infections but 13% of these people are unaware of their HIV infection. Current combination antiretroviral therapy (ART) does not cure HIV infection but rather suppresses the infection with the virus persisting indefinitely in latent reservoirs in the body. As a consequence of ART, HIV infection has changed from a fatal disease in the past to a chronic disease today. Currently in the United States, more than 45% of HIV+ individuals are greater than 50 years of age and 25% will be greater than 65 years of age by 2030. Atherosclerotic cardiovascular disease (CVD), including myocardial infarction, stroke, and cardiomyopathy, is now the major cause of death in HIV+ individuals. Novel risk factors, including chronic immune activation and inflammation in the body, antiretroviral therapy, and traditional CVD risk factors, such as tobacco and illicit drug use, hyperlipidemia, the metabolic syndrome, diabetes mellitus, hypertension, and chronic renal disease, contribute to cardiovascular atherosclerosis. This article discusses the complex interactions involving HIV infection, the novel and traditional risk factors for CVD, and the antiretroviral HIV therapies which can contribute to CVD in HIV-infected people. In addition, the treatment of HIV+ patients with acute myocardial infarction, stroke, and cardiomyopathy/heart failure are discussed. Current recommended ART and their major side effects are summarized in table format. All medical personnel must be aware of the increasing incidence of CVD on the morbidity and mortality in HIV infected patients and must be watchful for the presence of CVD in their patients with HIV.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 2","pages":"101-121"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193251/pdf/ajcd0013-0101.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10296975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Left lateral accessory pathway successfully ablated from within the coronary sinus, a case report.","authors":"Eyad Alhaj,&nbsp;Ali Alhaj","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>WPW (Wolff-Parkinson-White) syndrome is a congenital heart condition characterized by an abnormal accessory electrical pathway in the heart that can cause rapid heartbeat (supraventricular tachycardia). Radiofrequency ablation is considered the first-line treatment, it can be curative in almost 95% of patients. Sometimes ablation therapy can fail when the pathway is close to the epicardium. We hereby report a case of a patient with a left lateral accessory pathway. Several attempts of ablation from the endocardium targeting a clear pathway potential failed. Subsequently, the pathway was safely and successfully ablated from within the distal coronary sinus.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 2","pages":"68-72"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193246/pdf/ajcd0013-0068.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9507552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}